Cargando…
Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent
Genetic or pharmacological ablation of toll-like receptor 2 (TLR2) protects against myocardial ischemia/reperfusion injury (MI/R). However, the endogenous ligand responsible for TLR2 activation has not yet been detected. The objective of this study was to identify HMGB1 as an activator of TLR2 signa...
Autores principales: | Mersmann, Jan, Iskandar, Franziska, Latsch, Kathrina, Habeck, Katharina, Sprunck, Vera, Zimmermann, René, Schumann, Ralf R., Zacharowski, Kai, Koch, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859028/ https://www.ncbi.nlm.nih.gov/pubmed/24371373 http://dx.doi.org/10.1155/2013/174168 |
Ejemplares similares
-
The Early Activation of Toll-Like Receptor (TLR)-3 Initiates Kidney Injury after Ischemia and Reperfusion
por: Paulus, Patrick, et al.
Publicado: (2014) -
Toll-Like Receptors in Hepatic Ischemia/Reperfusion and Transplantation
por: Evankovich, John, et al.
Publicado: (2010) -
Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury
por: Zhao, Guangyuan, et al.
Publicado: (2017) -
Inhibiting HMGB1 Reduces Cerebral Ischemia Reperfusion Injury in Diabetic Mice
por: Wang, Chong, et al.
Publicado: (2016) -
Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
por: Kaczorowski, David J, et al.
Publicado: (2009)